TGFB1 and chronic kidney disease: These results suggest that measurement of urinary TGF-β1 levels at certain stages of the disease may be more useful than serum creatinine in predicting the progression to end stage renal disease and serve as a noninvasive adjunct in monitoring response to therapy [8].